Randhawa Simrat
CIK 1992260
Transactions on file
22
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-09-03 | 2026-09-01 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | Sale | 13,309 | $1.42M | -17.4% | open → |
| 2026-09-03 | 2026-09-01 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | Sale | 7,215 | $766.6K | -17.0% | open → |
| 2026-09-03 | 2026-09-01 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | Sale | 2,600 | $273.5K | -16.1% | open → |
| 2026-09-03 | 2026-09-01 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | Exer. | 9,375 | $206.9K | +299.7% | open → |
| 2026-09-03 | 2026-09-01 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | Exer. | 6,249 | $136.0K | +305.2% | open → |
| 2026-09-03 | 2026-09-01 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | Exer. | 7,500 | $134.1K | +393.3% | open → |
| 2026-06-02 | 2026-06-01 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | Sale | 4,159 | $380.0K | -3.5% | open → |
| 2026-06-02 | 2026-06-01 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | Sale | 16,943 | $1.54M | -2.8% | open → |
| 2026-06-02 | 2026-06-01 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | Sale | 5,428 | $487.0K | -1.7% | open → |
| 2026-06-02 | 2026-06-01 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | Exer. | 9,375 | $206.9K | +299.7% | open → |
| 2026-06-02 | 2026-06-01 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | Exer. | 6,249 | $136.0K | +305.2% | open → |
| 2026-06-02 | 2026-06-01 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | Exer. | 6,908 | $123.5K | +393.3% | open → |
| 2026-06-02 | 2026-06-01 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | Exer. | 3,998 | $33.7K | +945.1% | open → |
| 2025-11-14 | 2025-11-14 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | Sale | 109,031 | $4.16M | +131.3% | open → |
| 2025-11-14 | 2025-11-14 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | Exer. | 31,250 | $689.7K | +299.7% | open → |
| 2025-11-14 | 2025-11-14 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | Exer. | 37,494 | $816.2K | +305.2% | open → |
| 2025-11-14 | 2025-11-14 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | Exer. | 40,287 | $720.3K | +393.3% | open → |
| 2025-11-14 | 2025-11-13 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | Sale | 18,576 | $700.7K | +133.9% | open → |
| 2025-11-14 | 2025-11-13 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | Sale | 42,765 | $1.58M | +138.1% | open → |
| 2025-11-14 | 2025-11-13 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | Sale | 26,166 | $936.7K | +146.4% | open → |
| 2025-11-14 | 2025-11-13 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | Exer. | 3,529 | $63.1K | +393.3% | open → |
| 2025-11-14 | 2025-11-13 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | Exer. | 83,978 | $708.8K | +945.1% | open → |
